LGC Genomics

The firm has been piecing together a collection of acquisitions over recent years that expand its presence in the genomics market, particularly custom oligos.

LGC said that the acquisition will increase its presence in the nucleic acid market, in addition to its previous acquisitions in the last few years.

The UK-based firm plans to marry its core strengths with the probes and PCR platforms, and to build its sales force in the US. 

Integrated DNA Technologies has launched PrimeTime Eco Probes and PrimeTime Mini LNA Probes as part of its PrimeTime qPCR products portfolio.

NEW YORK (GenomeWeb News) – LGC Genomics and Covaris announced late on Wednesday a partnership to develop solutions for the high-throughput extraction of nucleic acids from formalin-fixed, paraffin-embedded tissue samples.

LGC Genomics said last week that it has expanded its nucleic acid extraction services to North America through the group's genomics laboratory in Beverly, Mass.
The new extraction service will complement existing capacity in Berlin and London, LGC said.

NEW YORK (GenomeWeb News) – Abbott's board of directors this week approved the separation of the firm's research-based pharmaceuticals business into a new company called AbbVie and declared a special dividend distribution for all of the outstanding shares of AbbVie common stock.

LGC Genomics, a division of the UK-based LGC Group that provides DNA and genetic analysis services, recently expanded its genotyping facilities to keep up with its sequencing-based SNP discovery services.

This story was originally published Aug. 8.

The data generated by 100,000 Genomes Project is being housed on military servers due to attacks by hackers, Naked Security reports.

A new poll finds most US adults are not familiar with personalized medicine, according to HealthDay.

Vox reports that the United Nations' Convention on Biological Diversity decided against a gene drive moratorium.

In Science this week: sequencing of neuroblastomas uncovers alterations linked to prognosis, and more.